- CMTA Event Schedule Update from CEO Amy GrayThe CMTA has decided to postpone and/or reschedule all upcoming CMTA branch meetings, events and walks originally scheduled to occur in March through May of 2020.Read more ...
- Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Charcot-Marie-Tooth DiseaseACE-083 did not achieve statistically significant improvements in functional endpoints relative to placebo; Acceleron to discontinue development of ACE-083.Read more ...
- Coronavirus (COVID-19) UpdateThe Centers for Disease Control and Prevention (CDC) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China.Read more ...
- CMTA Funds Cutting-Edge Gene Editing Studies for Type 2 CMTDrs. Bruce Conklin and Luke Judge will use a $653,000 grant from the CMTA to develop the gene-editing technique known as CRISPR for application to CMT2A, 2E and 2F.Read more ...
- The 2020 Winter CMTA ReportBe the Change: From attitude to exercise to research, in 2020 our CMTA family is committed to be the change we want to see in the world of CMT.Read more ...